|
| 37415222 | Targeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models. | J Transl Med | 2023 |
| 37526549 | Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047). | Neuro Oncol | 2023 |
| 35652336 | Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor. | Neuro Oncol | 2023 |
| 36950217 | Phase II study of everolimus for recurrent or progressive pediatric ependymoma. | Neurooncol Adv | 2023 |
| 34802040 | Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies. | Lab Invest | 2022 |
| 35611273 | Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. | Neurooncol Adv | 2022 |
| 36550163 | Publisher Correction: Epigenetic alterations of repeated relapses in patient-matched childhood ependymomas. | Nat Commun | 2022 |
| 36335125 | Epigenetic Alterations of Repeated Relapses in Patient-matched Childhood Ependymomas. | Nat Commun | 2022 |
| 35182954 | Synergistic anti-tumor efficacy of mutant isocitrate dehydrogenase 1 inhibitor SYC-435 with standard therapy in patient-derived xenograft mouse models of glioma. | Transl Oncol | 2022 |
| 35307742 | Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study. | Neuro Oncol | 2022 |
| 34907396 | Retraction Note: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma. | Nat Neurosci | 2022 |
| 33358190 | Corrigendum to "Impact of SCID mouse gender on tumorigenicity, xenograft growth and drug-response in a large panel of orthotopic PDX models of pediatric brain tumors" [Cancer Lett. 493 (2020) 197-206]. | Cancer Lett | 2021 |
| 33547201 | A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study. | Clin Cancer Res | 2021 |
| 33571520 | Neogenin is highly expressed in diffuse intrinsic pontine glioma and influences tumor invasion. | Brain Res | 2021 |
| 33739455 | Early radiotherapy preserves vision in sporadic optic pathway glioma. | Cancer | 2021 |
| 33631016 | A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study. | Neuro Oncol | 2021 |
| 34719887 | Spatial Dissection of Invasive Front from Tumor Mass Enables Discovery of Novel microRNA Drivers of Glioblastoma Invasion. | Adv Sci (Weinh) | 2021 |
| 34133064 | Gadolinium is not necessary for surveillance MR imaging in children with chiasmatic-hypothalamic low-grade glioma. | Pediatr Blood Cancer | 2021 |
| 34254296 | Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma. | Cancer | 2021 |
| 33405376 | A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042). | Pediatr Blood Cancer | 2021 |
| 33025730 | Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial. | Pediatr Blood Cancer | 2021 |
| 32285998 | A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma. | Pediatr Blood Cancer | 2020 |
| 31842647 | Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL). | Leuk Lymphoma | 2020 |
| 32009149 | A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study. | Neuro Oncol | 2020 |
| 33046443 | Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma. | Cancer Res | 2020 |
| 32891713 | Impact of SCID mouse gender on tumorigenicity, xenograft growth and drug-response in a large panel of orthotopic PDX models of pediatric brain tumors. | Cancer Lett | 2020 |
| 32502459 | Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. | Lancet Oncol | 2020 |
| 32241771 | Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium. | AJNR Am J Neuroradiol | 2020 |
| 32424282 | Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma. | Nat Neurosci | 2020 |
| 31151904 | Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. | Lancet Oncol | 2019 |
| 31693904 | Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design. | Cell Rep | 2019 |
| 29090526 | A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas. | Pediatr Blood Cancer | 2018 |
| 30355798 | Systems biology-based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma. | Sci Transl Med | 2018 |
| 29463553 | Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX Models. | Clin Cancer Res | 2018 |
| 28825123 | Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11). | Cancer Immunol Immunother | 2017 |
| 29152094 | Xenotransplantation of pediatric low grade gliomas confirms the enrichment of <i>BRAF</i> V600E mutation and preservation of <i>CDKN2A</i> deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytoma. | Oncotarget | 2017 |
| 26956263 | Preservation of KIT genotype in a novel pair of patient-derived orthotopic xenograft mouse models of metastatic pediatric CNS germinoma. | J Neurooncol | 2016 |
| 25542650 | Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma. | Radiother Oncol | 2015 |
| 24470556 | A patient tumor-derived orthotopic xenograft mouse model replicating the group 3 supratentorial primitive neuroectodermal tumor in children. | Neuro Oncol | 2014 |
| 25526772 | Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes. | Acta Neuropathol Commun | 2014 |
| 24460684 | Polycomb group gene BMI1 controls invasion of medulloblastoma cells and inhibits BMP-regulated cell adhesion. | Acta Neuropathol Commun | 2014 |
| 23658322 | Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma. | Neuro Oncol | 2013 |
| 22459127 | Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma. | Neuro Oncol | 2012 |
| 20563581 | Plasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primates. | Cancer Chemother Pharmacol | 2011 |
| 21075780 | A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models. | Neuro Oncol | 2011 |
| 20511191 | A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo. | Neuro Oncol | 2010 |
| 19006222 | Acquired von Willebrand syndrome and Wilms tumor: not always benign. | Pediatr Blood Cancer | 2009 |
| 18403755 | Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma. | Stem Cells | 2008 |